Estramustine phosphate sodium
Based on 1 publication(s) in Google Scholar
Estramustine phosphate sodium, an estradiol analog, is an orally active antimicrotubule chemotherapy agent. Estramustine phosphate sodium depolymerises microtubules by binding to microtubule associated proteins (MAPs) and/or to tubulin. Estramustine phosphate sodium can interfere mitosis, trigger cell death and induce apoptosis, which can be used for the research of cancer like prostate cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.60%
- CAS No.: 52205-73-9
- Formule: C23H30Cl2NNa2O6P
- Masse moléculaire:564.35
-
Stockage:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
Apoptosis Compound Library
HY-L003
-
Cell Cycle/DNA Damage Compound Library
HY-L004
-
Immunology/Inflammation Compound Library
HY-L007
-
FDA-Approved Drug Library
HY-L022
-
Anti-Cancer Compound Library
HY-L025
-
Anti-Aging Compound Library
HY-L034
-
Drug Repurposing Compound Library
HY-L035
-
Covalent Screening Library
HY-L036
-
Lipid Compound Library
HY-L043
-
Endocrinology Compound Library
HY-L047
-
NMPA-Approved Drug Library
HY-L053
-
Cytoskeleton Compound Library
HY-L060
-
Orally Active Compound Library
HY-L061
-
FDA Approved & Pharmacopeial Drug Library
HY-L066
-
Anti-Lung Cancer Compound Library
HY-L075
-
Drug-Induced Liver Injury (DILI) Compound Library
HY-L076
-
Protein-protein Interaction Inhibitor Library
HY-L109
-
Chemotherapy Drug Library
HY-L112
-
FDA-Approved Anticancer Drug Library
HY-L122
-
Anti-Prostate Cancer Compound Library
HY-L124
-
Off-patent Drug Library
HY-L141
-
Cell Death Library
HY-L162
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Covalent Screening Library Plus
HY-L036P
-
Drug Repurposing Compound Library Plus
HY-L035P
-
FDA-Approved Drug Library Plus
HY-L022P
-
FDA-Approved Drug Library Mini
HY-L022M
-
Bioactive Compound Library
HY-L001
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library
HY-L199
-
High-Throughput Bioactive Compound Library
HY-L205
-
Anti-Cancer Approved Drug Library
HY-L213
-
Cardiotoxic Compound Library
HY-L225
-
High-Efficiency Gene Editing Compound Library
HY-L244
Publications Citing Use of MedChemExpress (MCE) Estramustine phosphate sodium
More
Activité biologique
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| DU-145 | IC50 |
16 μM
Compound: Estramustine Phosphate Sodium
|
Antimitotic activity against human DU-145 cells assessed as reduction in cell proliferation incubated for 72 hrs by alamar blue based fluorescence spectrophotometric analysis
Antimitotic activity against human DU-145 cells assessed as reduction in cell proliferation incubated for 72 hrs by alamar blue based fluorescence spectrophotometric analysis
|
[PMID: 37948954] |
Estramustine phosphate sodium (1 µg/ mL, 48 h) suppresses PC3 cell growth[1]. Estramustine phosphate sodium (2 µg/mL, 48 h) elevates phosphatidylserine eversion amount on PC3 cells and induces PC3 cell apoptosis through reducing miR-31[1]. Estramustine phosphate sodium (0-40 µM, 24-72 h) inhibits cell proliferation and tubulin cytoskeleton in RAW 264.7 cells[2]. Estramustine phosphate sodium (10 µM, 24 h) inhibits TGF-β-induced RAW 264.7 cell migration, as well as TGF-β-induced uPA production by inhibiting Smad3 activation[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:PC3 cells
-
Concentration:1 µg/ mL
-
Incubation Time:48 h
-
Result:Suppressed PC3 cell growth.
-
Cell Line:RAW 264.7 cells
-
Concentration:10 µM
-
Incubation Time:24 h
-
Result:Disrupted the interphase microtubules.
-
Cell Line:18 h of TGF-β treated RAW 264.7 cells
-
Concentration:10 µM
-
Incubation Time:24 h
-
Result:Inhibited TGF-β-Induced Cell Migration.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Swiss nu/nu (nude) male mice (5-week-old) bearing PAC120 tumors[3]
-
Dosage:4 mg/kg, 12 mg/kg
-
Administration:Intraperitoneal injection; daily; for 2 weeks
-
Result:Suppressed the development of skin lesions and resulted in a dissociation between DTH response and antibody production.
-
Animal Model:Human prostate cancer xenograft PAC120[3]
-
Dosage:4 or 12 mg/kg, a daily dose for 2 weeks.
-
Administration:Intraperitoneal injection
-
Result:Inhibited PAC120 tumor growth 53% by day 35.
Chemical Information
-
CAS No. 52205-73-9
-
Appearance Solid
-
Masse moléculaire 564.35
-
Formule C23H30Cl2NNa2O6P
-
Color White to off-white
-
SMILES
O=C(N(CCCl)CCCl)OC1=CC2=C(C=C1)[C@@]3([H])CC[C@@]4(C)[C@](CC[C@@H]4OP(O[Na])(O[Na])=O)([H])[C@]3([H])CC2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications (1)
-
Journal Impact Factor
-
Most Recent
Solvant et solubilité
H2O : 62.5 mg/mL (110.75 mM; Need ultrasonic)
DMSO : 5 mg/mL (8.86 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (278 KB)
-
SDS (419 KB)
- English - EN (419 KB)
- Français - FR (419 KB)
- Deutsch - DE (419 KB)
- Norwegian - NO (419 KB)
- Español - ES (419 KB)
- Swedish - SV (419 KB)
- Italian - IT (419 KB)
- Korean - KR (419 KB)
- Portuguese - PT (419 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. C Wei, et al. Estramustine phosphate induces prostate cancer cell line PC3 apoptosis by down-regulating miR-31 levels. Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):40-45. [Content Brief]
[2]. Sonja S Mojsilovic, et al. Estramustine Phosphate Inhibits TGF- β-Induced Mouse Macrophage Migration and Urokinase-Type Plasminogen Activator Production. Anal Cell Pathol (Amst). 2018 Sep 2;2018:3134102. [Content Brief]
[3]. Stephane Oudard, et al. Activity of docetaxel with or without estramustine phosphate versus mitoxantrone in androgen dependent and independent human prostate cancer xenografts. J Urol. 2003 May;169(5):1729-34. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO / H2O | 1 mM | 1.7720 mL | 8.8598 mL | 17.7195 mL | 44.2988 mL |
| 5 mM | 0.3544 mL | 1.7720 mL | 3.5439 mL | 8.8598 mL | |
| H2O | 10 mM | 0.1772 mL | 0.8860 mL | 1.7720 mL | 4.4299 mL |
| 15 mM | 0.1181 mL | 0.5907 mL | 1.1813 mL | 2.9533 mL | |
| 20 mM | 0.0886 mL | 0.4430 mL | 0.8860 mL | 2.2149 mL | |
| 25 mM | 0.0709 mL | 0.3544 mL | 0.7088 mL | 1.7720 mL | |
| 30 mM | 0.0591 mL | 0.2953 mL | 0.5907 mL | 1.4766 mL | |
| 40 mM | 0.0443 mL | 0.2215 mL | 0.4430 mL | 1.1075 mL | |
| 50 mM | 0.0354 mL | 0.1772 mL | 0.3544 mL | 0.8860 mL | |
| 60 mM | 0.0295 mL | 0.1477 mL | 0.2953 mL | 0.7383 mL | |
| 80 mM | 0.0221 mL | 0.1107 mL | 0.2215 mL | 0.5537 mL | |
| 100 mM | 0.0177 mL | 0.0886 mL | 0.1772 mL | 0.4430 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Estramustine phosphate sodium Related Classifications
HY-13627 Related Classifications
Powered by Bioz